Evidence map›Paper›PMID 39520515›Full record

ReviewEuropean journal of nuclear medicine and molecular imaging2025

Expert consensus on workflow of PET/CT with long axial field-of-view.

Guobing Liu, Yushen Gu, Martina Sollini, Alexandra Lazar, Florent L Besson, Sijin Li, Zhifang Wu, Lorenzo Nardo, Akram Al-Ibraheem, Jiefu Zheng and 18 more

Abstract readReviewConsensus Statement
PubMed Publisher
In one paragraph

Review in European journal of nuclear medicine and molecular imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Eagle eyes on the human brain and beyond: PET at ultra-high spatial resolution.European journal of nuclear medicine and molecular imaging · 2026
    Article
  3. Article
  4. Article
  5. A scoping review on potential of novel developments in fever of unknown origin and inflammation of unknown origin: long-axial-field-of-view positron emission tomography/computed tomography and novel radiotracers.The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of... · 2025
    Article
  6. Total-bodyEJNMMI research · 2025
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors.

Guobing Liu *Shanghai Institute of Medical Imaging, Shanghai, 200032, P.R. China.
Yushen Gu *Department of Nuclear Medicine, Zhongshan Hospital, Fudan University, 180 Fenglin Road, Shanghai, 200032, P.R. China.
Martina Sollini *Vita-Salute San Raffaele University, Via Olgettina 58, 20132, Milan, Italy.
Alexandra LazarVita-Salute San Raffaele University, Via Olgettina 58, 20132, Milan, Italy.
Florent L BessonDepartment of Nuclear Medicine-Molecular Imaging, Hôpitaux Universitaires Paris-Saclay, AP-HP, DMU Smart Imaging, CHU Bicêtre, Paris, France and Université Paris-Saclay, Commissariat À L'énergie Atomique Et Aux Énergies Alternatives (CEA), Centre National de La Recherche Scientifique (CNRS), InsermBioMaps, Orsay, France.
Sijin LiDepartment of Nuclear Medicine, First Hospital of Shanxi Medical University, Collaborative Innovation Center for Molecular Imaging Precision Medicine, Taiyuan, 030001, P.R. China.
Zhifang WuDepartment of Nuclear Medicine, First Hospital of Shanxi Medical University, Collaborative Innovation Center for Molecular Imaging Precision Medicine, Taiyuan, 030001, P.R. China.
Lorenzo NardoDepartment of Radiology, University of California Davis, Sacramento, CA, 95819, USA.
Akram Al-IbraheemDepartment of Nuclear Medicine and PET/CT, King Hussein Cancer Center (KHCC), Al-Jubeiha, Amman, 11941, Jordan.
Jiefu ZhengDivision of Nuclear Medicine and Molecular Imaging, Department of Radiology and Medical Imaging, University of Virginia School of Medicine, 1215 Lee Street, Charlottesville, VA, 22908-0170, USA.
Harshad R KulkarniBAMF Health, Grand Rapids, MI, 49503, USA.
Axel RomingerDepartment of Nuclear Medicine, Inselspital, Bern University Hospital, University of Bern, Freiburgstrasse 18, CH-3010, Bern, Switzerland.
Wei FanDepartment of Nuclear Medicine, Sun Yat-Sen University Cancer Center, No. 651 Dongfengdong Road, Guangzhou, 510060, P.R. China.
Xiaohua ZhuDepartment of Nuclear Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Ave, Wuhan, 430030, P.R. China.
Xinming ZhaoDepartment of Nuclear Medicine, The Fourth Hospital of Hebei Medical University, Shijiazhuang, 050011, Hebei Province, P.R. China.
Hubing WuNanfang PET Center, Nanfang Hospital, Southern Medical University, 1838 Guangzhou Avenue North, Guangzhou, 510515, P.R. China.
Jianjun LiuDepartment of Nuclear Medicine, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, No. 160 PuJian Road, Shanghai, 200127, P.R. China.
Biao LiDepartment of Nuclear Medicine, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, No. 197 Ruijin Er Road, Shanghai, 200025, P.R. China.
Zhaoping ChengDepartment of Nuclear Medicine, The First Affiliated Hospital of Shandong First Medical University, No. 16766 Jingshi Road, Jinan, 250014, Shandong, P.R. China.
Ruimin WangDepartment of Nuclear Medicine, The First Medical Centre, Chinese PLA General Hospital, Beijing, 100853, P.R. China.
Baixuan XuDepartment of Nuclear Medicine, The First Medical Centre, Chinese PLA General Hospital, Beijing, 100853, P.R. China.
Denis AgostiniDepartment of Nuclear Medicine, University Hospital of Caen and Normandie Université, EA, 4650, Caen, France.
Han TangCancer Prevention and Treatment Center, Zhongshan Hospital, Fudan University, Shanghai, 200032, P.R. China.
Lijie TanCancer Prevention and Treatment Center, Zhongshan Hospital, Fudan University, Shanghai, 200032, P.R. China.
Zhi YangKey Laboratory of Carcinogenesis and Translational Research, (Ministry of Education/Beijing), NMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals, Department of Nuclear Medicine, Peking University Cancer Hospital & Institute, Beijing, 100142, P.R. China.
Li HuoDepartment of Nuclear Medicine, Beijing Key Laboratory of Molecular Targeted Diagnosis and Therapy in Nuclear Medicine, Beijing, 100730, P.R. China.
Jianying GuCancer Prevention and Treatment Center, Zhongshan Hospital, Fudan University, Shanghai, 200032, P.R. China. gu.jianying@zs-hospital.sh.cn.
Hongcheng ShiDepartment of Nuclear Medicine, Zhongshan Hospital, Fudan University, 180 Fenglin Road, Shanghai, 200032, P.R. China. shi.hongcheng@zs-hospital.sh.cn.ORCID 0000-0001-7457-876X

Funding

the Chinese National Key Clinical Specialty Program YWP2022-007the Innovative Medical Device Application Demonstration Program of Shanghai Municipal Commission of Economy and Informatization 23SHS01200the National Key Research and Development Program of China 2022YFC2406902
6 · The paper itself

Abstract

purposePositron emission tomography/computed tomography (PET/CT) imaging has been widely used in clinical practice. Long axial field-of-view (LAFOV) systems have enhanced clinical practice by leveraging their technological advantages and have emerged as the new state-of-the-art PET imaging modalities. A consensus was conducted to explore expert views in this emerging field to comprehensively elucidate the proposed workflow in LAFOV PET/CT examinations and highlight the potential challenges inherent in the workflow.

methodsA multidisciplinary task group formed by 28 experts from six countries over the world discussed and approved the consensus based on the published guidelines, peer-reviewed articles of LAFOV PET/CT, and the collective experience from clinical practice. This consensus focuses on the workflow that allows for a broader range of imaging protocols of LAFOV PET/CT, catering to diverse patient needs and in line with precision medicine principles.

resultsThis consensus describes the workflows and imaging protocols of LAFOV PET/CT for various imaging scenarios including routine static imaging, dynamic imaging, low-activity imaging, fast imaging, prolonged imaging, delayed imaging, and dual-tracer imaging. In addition, imaging reconstruction and reviewing specific to LAFOV PET/CT imaging, as well as the main challenges facing installation and application of LAFOV PET/CT scanner were also summarized.

conclusionThis consensus summarized the various imaging workflow, imaging protocol, and challenges of LAFOV PET/CT imaging, aiming to enhance the clinical and research applications of these scanners.

Indexed as

Positron Emission Tomography Computed TomographyWorkflowHumansImage Processing, Computer-AssistedExpert consensusImaging protocolsImaging workflowLong axial field-of-viewPositron emission tomography/computed tomography (PET/CT)Total-body imaging

Identifiers

PMID39520515

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.